Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0085584 (
encephalopathy
)
18,178
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The small intestinal absorption was comparatively studied in 49 patients with hypotrophy and
encephalopathy
(the test with
D-xylose
): 25 of them received balanced artificial feeding (control group), while 24 patients were also given protein enteral feeding formula [correction of enpit] and retabolil. Absorption disorders were revealed mainly in the proximal portion of the intestine, and its improvement under the influence of the protein-anabolic therapy was recorded.
D-xylose
renal excretion during 5 h in the treated patients was by 14.3% higher as compared to those in the control group, and it reached the standard level in the normal children (34.4 +/- 3.2%). Daily average increase of the body mass in patients who received the protein anabolic therapy was twofold higher than that in the children of the control group.
...
PMID:[The characteristics of absorption in the small intestine of young infants with hypotrophy and encephalopathy undergoing protein-anabolic therapy]. 234 8
The cause of bilirubin encephalopathy has been variously ascribed to elevated total serum bilirubin concentration, high free bilirubin levels (or impaired albumin binding), and disruption of the blood-brain barrier. An experimental rat model for acute bilirubin encephalopathy was developed in which these three factors could be varied independently. Osmotic opening of the blood-brain barrier in the right hemisphere was produced by infusing a hypertonic
arabinose
solution into the right carotid artery. The total bilirubin level and bilirubin binding state were varied by adjusting the amount of bilirubin infused intravenously and/or by infusing human serum albumin. Brain electrical activity (EEG) served as an indicator of developing
encephalopathy
. Neither staining nor EEG changes occurred if the blood-brain barrier remained intact. Bilirubin staining without EEG evidence of
encephalopathy
sometimes occurred when the blood-brain barrier was open. Discriminant analysis showed that EEG changes were best predicted by the degree of blood-brain barrier opening (as indicated by brain bilirubin content) and by the quality of serum bilirubin binding. Serum total bilirubin concentration was not an important discriminator of
encephalopathy
.
...
PMID:Experimental bilirubin encephalopathy: importance of total bilirubin, protein binding, and blood-brain barrier. 373 93
Although total diversion of portal blood flow has been considered to be the main factor leading to
encephalopathy
following nonselective shunt (NSS), increased intestinal absorption of cerebral toxins secondary to mesenteric venous decompression could also play a role. Conversely, the low frequency of
encephalopathy
after the distal splenorenal shunt (DSRS) may be due to preservation of both hepatic portal perfusion and mesenteric venous hypertension. Portal hemodynamics, intestinal absorption of
D-xylose
, ammonia metabolism, and clinical
encephalopathy
were assessed preoperatively and in the early and late postoperative periods in cirrhotic patients selected for the DSRS (n = 12) and NSS (n = 10). Preoperatively, NSS patients had significantly less hepatopetal portal blood flow (P = 0.03) and lower
D-xylose
absorption (P = 0.004) than DSRS patients. DSRS resulted in no significant alterations in hepatic portal perfusion, portal pressure,
D-xylose
absorption, fasting blood ammonia (NH3), or tolerance to an oral dose of ammonium chloride. In contrast, NSS resulted in complete portal diversion and decompression and significant enhancement of
D-xylose
absorption on both the early (P = 0.02) and late (P = 0.03) postoperative evaluations. Early and late postoperative levels of MH3 were significantly higher in NSS patients.
Encephalopathy
was more frequent after NSS (80%) than after DSRS (17%, P = 0.003). When all patients were considered, preoperative to early DSRS (17%, P = 0.003). When all patients were considered, preoperative to early postoperative change in NH3 correlated with change in
D-xylose
absorption (r = 0.52, p = 0.02), and there were significantly more individuals with a greater than 2 gm increase in
D-xylose
absorption who developed
encephalopathy
(83%) than patients with no or minimal increase in
D-xylose
absorption (33%, P = 0.04). The results of this study suggest that altered intestinal absorption may be one of many factors determining postshunt cerebral function.
...
PMID:Portal hemodynamics, intestinal absorption, and postshunt encephalopathy. 687 34